Checkpoint Capital »

Gh Research shares owned by Checkpoint Capital

Quarter-by-quarter ownership of Gh Research (GHRS) shares owned by Checkpoint Capital from 13F filings

Historical chart of Checkpoint Capital investment in Gh Research

Tip: Access up to 7 years of quarterly data

All positions including Gh Research held by Checkpoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gh Research by Checkpoint Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 294k 5.80

More positions owned by Checkpoint Capital

Rhythm Pharmaceuticals (RYTM)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Spdr Biotech Etf Tr Unit Put Option (XBI)
Ironwood Pharmaceuticals Com Cl A (IRWD)
Springworks Therapeutics (SWTX)
Axsome Therapeutics (AXSM)
Mirum Pharmaceuticals (MIRM)
Protagonist Therapeutics (PTGX)
Avadel Pharmaceuticals Sponsored Adr (AVDL)
Phathom Pharmaceuticals (PHAT)
Atyr Pharma Com New (LIFE)
Trevi Therapeutics (TRVI)
Gh Research Ordinary Shares (GHRS)
Allakos (ALLK)

View all positions for Checkpoint Capital

Top funds holding Gh Research

BVF
RA Capital Management
Lynx1 Capital Management
VR Adviser
Cormorant Asset Management
5AM Venture Management
Checkpoint Capital
Citadel Advisors
Millennium Management
Laurion Capital Management
Squarepoint Ops
Barclays
Bank of America Corporation
Two Sigma Investments
Tortoise Investment Management

View all funds holding Gh Research